Financial Counselors Inc. lowered its holdings in shares of Koninklijke Philips (NYSE:PHG – Free Report) by 5.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 129,570 shares of the technology company’s stock after selling 7,225 shares during the period. Financial Counselors Inc.’s holdings in Koninklijke Philips were worth $3,281,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of PHG. Sequoia Financial Advisors LLC lifted its position in shares of Koninklijke Philips by 4.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 8,932 shares of the technology company’s stock worth $226,000 after buying an additional 384 shares during the period. Dorsey & Whitney Trust CO LLC lifted its holdings in shares of Koninklijke Philips by 3.9% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 11,401 shares of the technology company’s stock valued at $289,000 after acquiring an additional 427 shares during the period. Legacy Wealth Asset Management LLC boosted its stake in shares of Koninklijke Philips by 1.1% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 51,331 shares of the technology company’s stock valued at $1,300,000 after purchasing an additional 562 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Koninklijke Philips by 37.1% in the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after purchasing an additional 582 shares during the last quarter. Finally, First Affirmative Financial Network boosted its position in Koninklijke Philips by 5.9% in the fourth quarter. First Affirmative Financial Network now owns 10,950 shares of the technology company’s stock valued at $277,000 after buying an additional 611 shares in the last quarter. Institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Stock Up 2.2 %
Shares of PHG opened at $25.70 on Friday. The business’s fifty day moving average price is $26.73 and its two-hundred day moving average price is $27.61. The firm has a market capitalization of $24.15 billion, a price-to-earnings ratio of -30.59, a PEG ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a 52 week low of $19.10 and a 52 week high of $32.91. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23.
Koninklijke Philips Cuts Dividend
The firm also recently announced an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be given a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is -89.29%.
Analyst Ratings Changes
A number of research firms recently weighed in on PHG. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, March 8th. Finally, BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.
Get Our Latest Stock Analysis on Koninklijke Philips
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- Consumer Staples Stocks, Explained
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What Are Dividend Champions? How to Invest in the Champions
- Top 3 Beverage Stocks Pouring Out Profits
- What is the Euro STOXX 50 Index?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.